Dow Up 1.24% Nasdaq Up 0.42%

AbbVie Inc. (ABBV)

-NYSE
61.02 Up 1.04(1.73%) 1:47PM EDT - Nasdaq Real Time Price
Prev Close:59.98
Open:60.00
Bid:61.28 x 100
Ask:61.26 x 600
1y Target Est:64.62
Beta:1.928
Next Earnings Date:31-Oct-14ABBV Earnings announcement
Day's Range:59.91 - 61.43
52wk Range:45.50 - 61.43
Volume:7,500,435
Avg Vol (3m):14,188,000
Market Cap:97.13B
P/E (ttm):23.65
EPS (ttm):2.58
Div & Yield:1.96 (3.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.73%97.13B
MRKUp 1.92%165.23B
NVSUp 0.89%223.11B
PFEUp 1.48%189.75B

Key Statistics

Forward P/E (1 yr):15.10
P/S (ttm):4.96
Ex-Dividend Date:13-Jan-15

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback